The Mechanisms Involved in the Impairment of Hematopoiesis after Autologous Bone Marrow Transplantation

References

• Frei E., III, Canellos G. P. Dose: a critical factor in cancer chemotherapy. Am. J. Med. 1980; 69: 585–594
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Storb R., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone marrow transplantation. N. Engl. J. Med. 1975; 292: 832–843
   PubMed Web of Science ®Google Scholar
• Fefer A., Buckner C. D., Thomas E. D., Chewer M. A., Clift R. A., Glucksberg H., Neiman P. E., Storb R. Cure of hematologic neoplasia with transplantation of marrow from identical twins. N. Engl. J. Med. 1977; 297: 146–147
   PubMed Web of Science ®Google Scholar
• Gorin N. C., Herve P., Aegerter P., Goldstone A., Linch D., Maraninchi D., Burnett A., Helbig W., Meloni G., Verdonck L. F., De Witte T., Rizzoli V., Carella A., Parlier Y., Auvert B., Goldman J. Autologoub bone marrow transplantation for acute leukaemia in remission. Br. J. Haematol. 1986; 64: 385–395
   PubMed Web of Science ®Google Scholar
• O'Reilly R. J. Allogenic bone marrow transplantation: current status and future directions. Blood 1983; 62: 941–964
   PubMed Web of Science ®Google Scholar
• Reiffers J., Gaspard M. H., Maraninchi D., Michallet M., Marit G., Stoppa A. M., Corront B., David B., Gastaut J. A., Sotto J. J., Broustet A., Carcassonne Y., Hollard D. Comparison of allogenic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br. J. Haematol. 1989; 72: 57–63
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. J., Ritz J., Nadler L. M. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B‐cell lymphoma. N. Engl. J. Med. 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Antin J. H. Graft‐versus‐leukemia: no longer an epiphenomenon. Blood 1993; 82: 2273–2277
   PubMed Web of Science ®Google Scholar
• Barrett A. J., Adams J. A proliferative defect of human bone marrow after transplantation. Br. J. Haematol. 1981; 49: 159–164
   PubMed Web of Science ®Google Scholar
• Li S., Champlin R., Fitchen J. H., Gale R. P. Abnormalities of myeloid progenitor cells after “successful” bone marrow transplantation. J. Clin. Invest 1985; 75: 234–241
   PubMed Web of Science ®Google Scholar
• Arnold R., Schmeiser T., Heit W., Frickhofen N., Pabst G., Heimpel H., Kubanek B. Hemopoietic reconstitution after bone marrow transplantation. Exp. Hematol. 1986; 14: 271–277
   PubMed Web of Science ®Google Scholar
• Ma D. D. F., Varga D. E., Biggs J. C. Haemopoietic reconstitution after allogenic bone marrow transplantation in man: recovery of haemopoietic progenitors (CFU‐Mix. BFU‐E and CFU‐GM). Br. J. Haematol. 1987; 65: 5–10
   PubMed Web of Science ®Google Scholar
• Messner H. A., Curtis J. E., Minden M. D., Tritchler D., Lockwood G., Takahashi T., Lepine J., Jamal N., Tweeddale M., Wandl U. Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 1987; 70: 1425–1432
   PubMed Web of Science ®Google Scholar
• Vellenga E., Sizoo W., Hagenbeek A., Löwenberg B. Different repopulation kinetics of erythroid (BFU‐E), myeloid (CFU‐GM) and T lymphocyte (TL‐CFU) progenitor cells after autologous and allogenic bone marrow transplantation. Br. J. Haematol. 1987; 65: 137–142
   PubMed Web of Science ®Google Scholar
• Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transpl. 1990; 5: 209–226
   PubMed Web of Science ®Google Scholar
• Keating A., Singer J. W., Killen P. D., Striker G. E., Salo A. C., Sanders J., Thomas E. D., Thorning D., Fialkow P. J. Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature 1982; 298: 280–283
   PubMed Web of Science ®Google Scholar
• Laver J., Jhanwar S. L., O'Reilly R. J., Castro‐Malaspina H. Host origin of the human hematopoietic microenvironment following allogenic bone marrow transplantation. Blood 1987; 70: 1966–1968
   PubMed Web of Science ®Google Scholar
• Deeg H. J., Witherspoon R. P. Risk factors for the development of secondary malignancies after marrow transplantation. Hemat. Oncol. Clin. North Am. 1993; 7: 417–430
   PubMed Web of Science ®Google Scholar
• Miller J. S., Arthur D. C., Litz C. E., Neglia J. P., Miller W. J., Weisdorf D. J. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780–3786
   PubMed Web of Science ®Google Scholar
• Mauch P., Ferrara J., Hellman S. Stem cell self‐renewal considerations in bone marrow transplantation. Bone Marrow Transpl. 1989; 4: 601–607
   PubMed Web of Science ®Google Scholar
• Wolf N. S., Kone A., Priestlez G. V., Bartelmez S. H. In vivo and in vitro characterization of long term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342‐rhodamine 123 FACS selection. Exp. Hematol. 1993; 21: 614–622
   PubMed Web of Science ®Google Scholar
• Szilvassy S. J., Fraser C. C., Eaves C. J., Landsdorp P. M., Eaves A. C., Humphries R. K. Retrovirus‐mediated gene transfert to purified hemopoietic stem cells with long‐term lympho‐myelopoietic repopulating ability. Proc. Natl. Acad. Sci. USA 1989; 86: 8798–8802
   PubMed Web of Science ®Google Scholar
• Martin P. J., Hansen J. A., Torok‐Storb B., Durnam D., Przepiorka D., O'Quigley J., Sanders J., Sullivan K. M., Witherspoon R. P., Degg H. J., Applebaum F. R., Stewart P., Weiden P., Doney K., Buckner C. D., Clift R., Storb R., Thomas E. D. Graft failure in patients receiving T cell‐depleted HLA‐identical allogenic marrow transplants. Bone Marrow Transpl. 1988; 3: 445–456
   PubMed Web of Science ®Google Scholar
• Sahdev I., O'Reilly R., Hoffmann M. K. Correlation between interleukin 1 production and engraftment of transplanted bone marrow stem cells in patients with lethal immunodeficiencies. Blood 1989; 73: 1712–1719
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Garcia‐Lopez J., Kalamasz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D., Thomas E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722
   PubMed Web of Science ®Google Scholar
• Gorin N. C., Lopez M., Laporte J. P., Quittet P., Lesage S., Lemoine F., Berenson R. J., Isnard F., Grande M., Stachowiak J., Labopin M., Fouillard L., Morel P., Jouet J. P., Noel‐Walter M. P., Detourmignies L., Aoudjhane M., Bauters F., Najman A., Doudy L. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non‐Hodgkin's lymphoma. Blood 1995; 85: 1647–1654
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Torok‐Storb B. Identification of stromal cell precursors: in human bone marrow by a novel monoclonal antibody STRO‐1. Blood 1991; 78: 55–69
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Przepiorka D., Thomas E. D., Torok‐Storb B. Host origin of bone marrow stromal cells following allogenic bone marrow transplantation. Nature 1987; 328: 429–432
   PubMed Web of Science ®Google Scholar
• Torok‐Storb B., Holmberg L. Role of marrow microenvironment in engraftment and maintenance of allogenic hematopoietic stem cells. Bone Marrow Transpl. 1994; 14(suppl. 4)S71–S73
   PubMedGoogle Scholar
• Schofield R. The relationship between the spleen colony‐forming cell and the haemopoietic stem cell. A hypothesis. Blood Cells 1978; 4: 1–25
   Google Scholar
• Down J. D., Ploemacher R. E. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp. Hematol. 1993; 21: 913–921
   PubMed Web of Science ®Google Scholar
• Brecher G., Ansell J. D., Micklem H. S., Tijio J. H., Cronkite E. P. Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngenic mice. Proc. Natl. Acad. Sci. USA 1982; 79: 5085–5087
   PubMed Web of Science ®Google Scholar
• Tavassoli M. The role of conditioning regimens in homing of transplanted hemopoietic cells. Bone Marrow Transplant. 1992; 10: 15–17
   PubMed Web of Science ®Google Scholar
• Tavassoli M., Hardy C. L. Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 1990; 76: 1059–1070
   PubMed Web of Science ®Google Scholar
• Aizawa S., Tavassoli M. Molecular basis of the recognition of intravenously transplanted hemopoietic cells by bone marrow. Proc. Natl. Acad. Sci. USA 1988; 85: 3180–3183
   PubMed Web of Science ®Google Scholar
• Konno M., Hardy C., Tavassoli M. Murine spleen culture: homing of hemopoietic progenitor cells to spleen is not mediated by similar mechanism to that in marrow. Exp. Hematol. 1990; 18: 65–68
   PubMed Web of Science ®Google Scholar
• Tavassoli M., Konno M., Shiota Y., Omoto E., Minguell J., Zanjani E. D. Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin‐3 and granulocyte‐macrophage colony‐stimulating factor. Blood 1991; 77: 1599–1606
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Masinovsky B., Longenecker B. M., Berenson R., Torok‐Storb B., Gallatin W. M. Vascular cell adhesion molecule‐I expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992; 80: 388–395
   PubMed Web of Science ®Google Scholar
• Levesque J. P., Leavesley D. I., Niutta S., Vadas M., Simmons P. J. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)‐4 and VLA‐5 integrins. J. Exp. Med. 1995; 181: 1805–1815
   PubMed Web of Science ®Google Scholar
• Arnold R., Calvo W., Heymer B., Schmelser T., Heimpel H., Kubanek B. Extramedullary haemopoiesis after bone marrow translantation. Scand, J. Haematol. 1985; 34: 9–12
   PubMedGoogle Scholar
• Jones R. J., Celano P., Sharkis S. J., Sensenbrenner L. L. Two phases of engraftment established by serial bone marrow transplantation in mice. Blood 1989; 73: 397–401
   PubMed Web of Science ®Google Scholar
• Smith L. G., Weissman I. L., Heimfeld S. Clonal analysis of hematopoietic stem‐cell differentiation in vivo. Proc. Natl. Acad. Sci. USA 1991; 88: 2788–2792
   PubMed Web of Science ®Google Scholar
• Brecher G., Bookstein N., Redfearn W., Necas E., Pallavicini M. G., Cronkite E. P. Self‐renewal of the long‐term repopulating stem cell. Proc. Natl. Acad. Sci. USA 1993; 90: 6028–6031
   PubMed Web of Science ®Google Scholar
• Neben S., Redfearn W. J., Parra M., Brecher G., Pallavicini M. G. Short‐ and long‐term repopulation of lethally irradiated mice by bone marrow stem cells enriched on the basis of light scatter and Hoechst 33342 fluorescence. Exp. Hematol. 1991; 19: 958–967
   PubMed Web of Science ®Google Scholar
• Abkowitz J. L., Linenberger M. L., Newton M. A., Shelton G. H., Ott R. L., Guttorp P. Evidence for the maintenance of hematopoiesis in a large animal by sequential activation of stem‐cell clones. Proc. Natl. Acad. Sci. USA 1990; 87: 9062–9066
   PubMed Web of Science ®Google Scholar
• Nash R., Storb R., Neiman P. Polyclonal reconstitution of human marrow after allogenic bone marrow transplantation. Blood 1988; 72: 2031–2037
   PubMed Web of Science ®Google Scholar
• Abkowitz J. L., Linenberger M. L., Persik M., Newton M. A., Guttorp P. Behavior of feline hematopoietic stem cells years after busulfan exposure. Blood 1993; 82: 2096–2103
   PubMed Web of Science ®Google Scholar
• Saunders M. J., Jowitt S. N., Liu Yin J. A. Clonality studies in patients undergoing allogenic and autologous bone marrow transplantation for haematological malignancies. Bone Marrow Transplant. 1995; 15: 81–85
   PubMed Web of Science ®Google Scholar
• van Leeuwen J. E., van Tol M. J., Joosten A. M., Wijnen J. T., Verweij P. J., Khan P. M., Vossen J. M. Persistence of host‐type hematopoiesis after allogenic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood 1994; 83: 3059–3067
   PubMed Web of Science ®Google Scholar
• Cahn J. Y., Hervé P., Flesch M., Plouvier E., Noir A., Racadot E., Montcuquet P., Behar C., Pignon B., Boilletot A., Lutz P., Henon P., Rozenbaum A., Peters A., Lecomte des Floris R. Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 cases. Br. J. Haematol. 1986; 63: 457–470
   PubMed Web of Science ®Google Scholar
• Gorin N. C., Douay L., Laporte J. P., Lopez M., Mary J. Y., Najman A., Salmon C., Aegerter P., Stachowiak J., David R., Pene F., Kantor G., Deloux J., Duhamel E., Van Den Akker J., Gerota J., Parlier Y., Duhamel G. Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia. Blood 1986; 67: 13677–1376
   Google Scholar
• Yeager A. M., Kaiser H., Santos G. W., Saral R., Colvin O. M., Stuart R. K., Braine H. G., Burke P. J., Ambinder R. F., Bums W. H., Fuller D. J., Davis J. M., Karp J. E., May W. S., Rowley S. D., Sensenbrenner L. L., Vogelsang G. B., Wingard J. R. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4‐Hydroperoxycyclophosphamide. N. Engl. J. Med. 1986; 315: 141–147
   PubMed Web of Science ®Google Scholar
• To L. B., Roberts M. M., Haylock D. N., Dyson P. G., Branford A. L., Thorp D., Ho J. Q. K., Dart G. W., Horvath N., Davy M. L. J., Olweny C. L. M., Abdi E., Juttner C. A. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transpl. 1992; 9: 277–284
   PubMed Web of Science ®Google Scholar
• Harada M., Yoshida T., Ishino C., Matsue K., Kodo H., Mori T., Shiobara S., Odaka K., Othake S., Kondo K., Nakao S., Ueda M., Hattori K., The Kanazawa University Bone Marrow Transplant Team. Hematologic recovery following autologous and allogenic bone marrow transplantation. Exp. Hematol. 1983; 11: 841–848
   PubMed Web of Science ®Google Scholar
• Sosa R., Weiden P. L., Storb R., Syrotuck J., Thomas E. D. Granulocyte function in human allogenic marrow graft recipients. Exp. Hematol. 1980; 8: 1183–1189
   PubMed Web of Science ®Google Scholar
• Alter B. P., Rappeport I. M., Huisman T. H., Schroeder W. A., Nathan D. G. Fetal erythropoiesis following bone marrow transplantation. Blood 1976; 48: 843–853
   PubMed Web of Science ®Google Scholar
• Betticher D. C., Huxol H., Müller R., Speck B., Nissen C. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for acute leukemia and severe aplastic anemia. Exp. Hematol. 1993; 21: 1517–1521
   PubMed Web of Science ®Google Scholar
• Novitzky N., Mohamed R. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Exp. Hematol. 1995; 23: 1661–1666
   PubMed Web of Science ®Google Scholar
• Spitzer G., Verma D. S., Fischer R., Zander A., Vellekoop L., Litam J., McCredie K. B., Dicke K. A. The myeloid progenitor cell—Its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 1980; 55: 317–323
   PubMed Web of Science ®Google Scholar
• Douay L., Gorin N. C., Mary J. Y., Lemarie E., Lopez M., Najman A., Stachowiak J., Giarratana M. C., Baillou C., Salmon C., Duhamel G. Recovery of CFU‐GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraft‐ment. Exp. Hematol. 1986; 14: 358–365
   PubMed Web of Science ®Google Scholar
• Lazarus H. M., Andersen J., Chen M. G., Variakojis D., Mansour E. G., Oette D., Arce C. A., Oken M. M., Gerson S. L. Recombinant Granulocyte‐Macrophage Colony‐Stimulating Factor after autologous bone marrow transplantation for relapsed non‐Hodgkin's lymphoma blood and bone marrow transplantation studies. A phase II Eastern Cooperative Oncology Group trial. Blood 1991; 78: 830–837
   PubMed Web of Science ®Google Scholar
• Kwong Y. L., Millar J. L., Powles R. L. Recovery of circulating haemopoietic progenitor cells in the early phase of haemopoietic reconstitution after autologous and allogenic bone marrow transplantation. Bone Marrow Transpl. 1989; 4: 575–578
   PubMed Web of Science ®Google Scholar
• Domenech J., Linassier C., Gihana E., Dayan A., Truglio D., Bout M., Petitdidier C., Delain M., Petit A., Bremond J. L., Desbois I., Lamagnere J. P., Colombat P., Binet C. Prolonged impairment of hematopoiesis after high‐dose therapy followed by autologous bone marrow transplantation. Blood 1995; 85: 3320–3327
   PubMed Web of Science ®Google Scholar
• Haas R., Witt B., Möhle R., Goldschmidt H., Hohaus S., Fruehauf S., Wannenmacher M., Hunstein W. Sustained long‐term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995; 85: 3754–3761
   PubMed Web of Science ®Google Scholar
• Mauch P., Hellman S. Loss of hematopoietic stem cell self‐reneval after bone marrow transplantation. Blood 1989; 74: 872–875
   PubMed Web of Science ®Google Scholar
• Bacigalupo A., Figari O., Tong J., Piaggio G., Miceli S., Frassoni F., Caciagli P., Badolati G., Marmont A. M. Long‐term marrow culture in patients with aplastic anemia compared with marrow transplant recipients and normal controls. Exp. Hematol. 1992; 20: 425–430
   PubMed Web of Science ®Google Scholar
• Albin N., Douay L., Fouillard L., Laporte J. P., Isnard F., Lesage S., Ozsahin H., Bardinet D., Najman A., Gorin N. C. In vivo effects of GM‐CSF and IL‐3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide‐purged marrow in lymphoid malignancies. Bone Marrow Transpl. 1994; 14: 253–259
   PubMed Web of Science ®Google Scholar
• Domenech J., Gihana E., Dayan A., Truglio D., Linassier C., Desbois I., Lamagnere J. P., Colombat P., Binet C. Haemopoiesis of transplanted patients with autologous marrows assessed by long‐term marrow culture. Br. J. Haematol. 1994; 88: 488–896
   PubMed Web of Science ®Google Scholar
• Domenech J., Heraud N., Dayan A., Estienne M. H., Linassier C., Colombat P., Binet C. Decreased proliferative capacity of marrow CD34+ cells after autologous bone marrow transplantation. Exp. Haematol. 1995; 23: 803, abstr
   Web of Science ®Google Scholar
• Bierkens J. G., Hendry J. H., Testa N. G. The radiation response and recovery of bone marrow stroma with particular reference to long‐term bone marrow cultures. Eur. J. Haematol. 1989; 43: 95–107
   PubMed Web of Science ®Google Scholar
• Testa N. G., Hendry J. H., Molineux G. Long‐term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. Anticancer Res. 1985; 5: 101–110
   PubMed Web of Science ®Google Scholar
• Bierkens J. G., Hendry J. H., Testa N. G. Recovery of the proliferative and functional integrity of mouse bone marrow in long‐term cultures established after whole‐body irradiation at different doses and dose rates. Exp. Hematol. 1991; 19: 81–86
   PubMed Web of Science ®Google Scholar
• Imai Y., Nakao I. In vivo radiosensivity and recovery pattern of the hematopoietic precursor cells and stem cells in mouse bone marrow. Exp. Hematol. 1987; 15: 890–895
   PubMed Web of Science ®Google Scholar
• Van den Berg H., van Tol M. J. D., Waaijer J. L. M., Oudeman‐Gruber N. J., Vossen J. M. Study of possible correlations between in vitro growth of bone marrow stromal and hematopoietic precursor cells early after allogenic bone marrow transplantation. Exp. Hematol. 1992; 20: 184–191
   PubMed Web of Science ®Google Scholar
• Da W. M., Ma D. D. F., Biggs J. C. Studies of hemopoietic stromal fibroblastic colonies in patients undergoing bone marrow transplantation. Exp. Hematol. 1986; 14: 266–270
   PubMed Web of Science ®Google Scholar
• Rice A., Reiffers J., Bernard P., Fourès C., Bascans E., Lacombe F., Marit G., Broustet A. Incomplete stroma formation after allogenic marrow or autologous blood stem cell transplantation. Now. Rev. Hematol. 1992; 34: 1–6
   PubMedGoogle Scholar
• Roingeard F., Domenech J., Lecron J. C., Colombat P., Binet C. Cytokines released by stromal cells after autologous bone marrow transplantation. Exp. Hematol. 1995; 23: 799, abstr
   Web of Science ®Google Scholar
• Cairo M. S., Gillan E. R., Weinthal J., Yancik S., Van de Ven C., Ho W., Shen V., Buzby J. S., Suen Y. Decreased endogenous circulating Steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post‐BMT myeloid engraftment. Bone Marrow Transpl. 1993; 11: 155–161
   PubMed Web of Science ®Google Scholar
• Migliaccio A. R., Migliaccio G., Johnson G., Adamson J. W., Torok‐Storb B. Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood 1990; 75: 305–312
   PubMed Web of Science ®Google Scholar
• Millar B. C., Bell J. B. G., Millar J. L., Treleaven J., Montes A., Joffe J. K., Powles R. L., McElwain T. J. Colony‐stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM‐CSF in vivo and interleukin 4 in vitro. Exp. Hematol. 1992; 20: 209–215
   PubMed Web of Science ®Google Scholar
• Cairo M. S., Suen Y., Sender L., Gillan E. R., Ho W., Plunkett J. M., Van de Ven C. Circulating granulocyte colony‐stimulating factor (G‐CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G‐CSF production correlates with myeloid engraftment. Blood 1992; 79: 1869–1873
   PubMed Web of Science ®Google Scholar
• Haas R., Gericke G., Witte B., Cayeux S., Hunstein W. Increased serum levels of granulocyte colony‐stimulating factor after autologous bone marrow or blood stem cell transplantation. Exp. Hematol. 1993; 21: 109–113
   PubMed Web of Science ®Google Scholar
• Mangan K. F., Mullaney M. T., Diaz Barrientos T., Kernan N. A. Serum interleukin‐3 levels following autologous or allogeneic bone marrow transplantation: effects of T‐cell depletion, blood stem cell infusion, and hematopoietic growth factor treatment. Blood 1993; 81: 1915–1922
   PubMed Web of Science ®Google Scholar
• Bosi A., Vannucchi A. M., Grossi A., Guidi S., Vannucchi L., Saccardi R., Bernabei P. A., Longo G., Rafanelli D., Rossi‐Ferrini P. Serum erythropoietin levels in patients undergoing bone marrow transplantation. Bone Marrow Transpl. 1991; 7: 421–425
   PubMed Web of Science ®Google Scholar
• Takamatsu Y., Akashi K., Harada M., Teshima T., Inaba S., Shimoda K., Eto T., Shibuya T., Okamura S., Niho Y. Cytokine production by peripheral blood monocytes and T‐cells during haemopoietic recovery after intensive chemotherapy. Br. J. Haematol. 1993; 83: 21–27
   PubMed Web of Science ®Google Scholar
• Emerson S. G., Sieff C. A., Gross R. G., Rozans M. K., Miller R. A., Rappeport J. M., Nathan D. G. Decreased hematopoietic accessory cell function following bone marrow transplantation. Exp. Hematol. 1987; 15: 1013–1021
   PubMed Web of Science ®Google Scholar
• Atkinson K., Seymour R., Altavilla N., Cooky M., Biggs J. Cytokine activity after allogenic bone marrow transplantation, IV. Production of mRNA for IL‐3 and GM‐CSF by mitogen‐stimulated circulating mononuclear cells. Bone Marrow Transpl. 1992; 9: 175–183
   PubMed Web of Science ®Google Scholar
• Lum L. G., Joshi I. D., Smith M. R., Ratanatharathom V., Galoforo S. C., Karanes C., Uberti J. P., Sensenbrenner L. L. Constitutive and mitogen‐stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogenic bone marrow recipients is intact. Bone Marrow Transpl. 1994; 13: 187–195
   PubMed Web of Science ®Google Scholar
• Roingeard F., Domenech J., Gihana E., Dayan A., Colombat P., Binet C. Cytokine production in long‐term marrow cultures after autologous BMT. Bone Marrow Transpl. 1995; 15: 741–747
   PubMed Web of Science ®Google Scholar
• Reittie J. E., Gottlieb D., Heslop H. E., Leger O., Drexler H. G., Hazlehurst G., Hoffbrand A. V., Prentice H. G., Brenner M. K. Endogenously generated activated killer cells circulate after autologous and allogenic marrow transplantation but not after chemotherapy. Blood 1989; 73: 1351–1358
   PubMed Web of Science ®Google Scholar
• Bengtsson M., Totterman T. H., Smedmyr B., Festin R., Oberg G., Simonsson B. Regeneration of functional and activated NK and T sub‐subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 23–color FACS analysis. Leukemia 1989; 3: 68–75
   PubMed Web of Science ®Google Scholar
• Domenech J., Linassier C., Canepa S., Buraschi J. P., Desbois I., Bremond J. L., Colombat P., Lamagnere J. P., Binet C. Modification of marrow cell immuno‐phenotype after autologous bone marrow transplantation. Exp. Hematol. 1991; 19: 562, abstr
   Web of Science ®Google Scholar
• Le Blanc G., Douay L., Laporte J. P., Dominh A., Deloux J., Najman A., Duhamel G., Gorin N. C. Evaluation of lymphocyte subsets after autologous bone marrow transplantation with marrow treated by Asta Z 7557 in acute leukemia: incidence of the in vitro treatment. Exp. Hematol. 1986; 14: 366–371
   PubMed Web of Science ®Google Scholar
• Bosly A. E., Staquet P. J., Doyen C. M., Chatelain B. J., Humblet Y. P., Symann M. L. Recombinant human interleukin‐2 restores in vitro T‐cell colony formation by peripheral blood mononuclear cells after autologous bone marrow reansplantation. Exp. Hematol. 1987; 15: 1048–1054
   PubMed Web of Science ®Google Scholar
• Vinci G., Vernant J. P., Cordonnier C., Henri A., Breton‐Gorius J., Rochant H., Vainchenker W. In vitro inhibition of hematopoiesis by HNKI, DR‐positive T cells and monocytes after allogenic hone marrow transplantation. Exp. Hematol. 1987; 15: 54–64
   PubMed Web of Science ®Google Scholar
• Cayeux S., Meuer S., Pezzutto A., Körbling M., Haas R., Schulz R., Dörken B. T‐cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin‐2 (IL‐2) and lack of CD2– and CD3‐mediated proliferation by both CD4+ and CD8+ cells even in the presence of exogenous IL‐2. Blood 1989; 74: 2270–2277
   PubMed Web of Science ®Google Scholar
• Mitus A. J., Stein R., Rappeport J. M., Antin J. H., Weinstein H. J., Alper C. A., Smith B. R. Monoclonal and oligoclonal gammopathy after hone marrow transplantation. Blood 1989; 74: 2764–2768
   PubMed Web of Science ®Google Scholar
• Minchinton R. M., Waters A. H., Malpas J. D., Gordon‐Smith E. C., Barett A. J. Selective thrombocytopenia and neutropenia occuring after hone marrow transplantation. Evidence of an autoimmune basis. Clin. Lab. Haematol. 1984; 6: 157–159
   PubMedGoogle Scholar
• Bashey A., Owen I., Lucas G. F., Amphlett N. W., Jones M. M., Lawal A., Mc Mullin M. F., Mahendra P., Tyfield L. A., Hows J. M. Late onset immune pancytopenia following bone marrow transplantation. Br. J. Haematol. 1991; 78: 268–274
   PubMed Web of Science ®Google Scholar
• Faille A., Maraninchi D., Gluckman E., Devergie A., Balitrand N., Ketels F., Dresch C. Granulocyte progenitor compartments after allogeneic hone marrow grafts. Scand, J. Haematol. 1981; 26: 202–214
   PubMedGoogle Scholar
• Rowley S. D., Zuehlsdorf M., Braine H. G., Colvin O. M., Davis J., Jones R. J., Sral R., Sensenbrenner L. L., Yeager A., Santos G. W. CFU‐GM content of hone marrow graft correlates with time to hematologic reconstitution following autologous hone marrow transplantation with 4‐hydroperoxycyclophosphamide‐purged hone marrow. Blood 1987; 70: 271–275
   PubMed Web of Science ®Google Scholar
• Neben S., Hemman S., Montgomery M., Ferrara J., Mauch P. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp. Hematol. 1993; 21: 156–162
   PubMed Web of Science ®Google Scholar
• Chang J., Geary C. G., Testa N. G. Long‐term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br. J. Haematol. 1990; 75: 68–72
   PubMed Web of Science ®Google Scholar
• Bhavnani M., Jones P. H. M., Testa N. G. Children in long‐term remission after treatment for acute lymphoblastic leukaemia show persisting haemopoietic injury in clonal and long‐term cultures. Br. J. Haematol. 1989; 71: 37–41
   PubMed Web of Science ®Google Scholar
• Visani G., Dinota A., Verlicchi F., Bandini G., Ricci P., Motta M. R., Rizzi S., Lemoli R. M., Poluzzi C., Gherlinzoni F., Calori E., Mazza P., Tura S. Autologous hone marrow transplantation in patients with non‐Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery. Bone Marrow Transpl. 1988; 3: 599–605
   PubMed Web of Science ®Google Scholar
• Brandwein J. M., Callum J., Sutcliffe S. B., Scott J. G., Keating A. Analysis of factors affecting hematopoietic recovery after autologous hone marrow transplantation for lymphoma. Bone Marrow Transpl. 1990; 6: 291–294
   PubMed Web of Science ®Google Scholar
• Henon P. R., Liang H., Beck‐Wirth G., Eisenmann J. C., Lepers M., Wunder E., Kandel G. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transpl. 1992; 9: 285–291
   PubMed Web of Science ®Google Scholar
• Udomsakdi C., Landsorp P. M., Hogge D. E., Reid D. S., Eaves A. C., Eaves C. J. Characterization of primitive hematopotetic cells in normal human peripheral blood. Blood 1992; 80: 2513–2521
   PubMed Web of Science ®Google Scholar
• Sutherland H. J., Eaves C. J., Lansdorp P. M., Phillips G. L., Hogge D. E. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808–3814
   PubMed Web of Science ®Google Scholar
• Benhoubker L., Domenech J., Linassier C., Desbois I., Delain M., Lamagnere J. P., Colomhat P., Binet C. Long‐term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM‐CSF. Exp. Hematol. 1995; 23: 1568–1573
   PubMed Web of Science ®Google Scholar
• Douay L., Gorin N. C., Laporte J. P., Lopez M., Najman A., Duhamel G. Asta Z 7557 (INN mafosfamide) for the in vivo treatment of human leukemic hone marrows. Invest. New Drugs. 1984; 2: 187–190
   PubMed Web of Science ®Google Scholar
• Winton E. F., Colenda K. W. Use of long‐term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4‐Hydroperoxycyclophosphamide. Exp. Hematol. 1987; 15: 710–714
   PubMed Web of Science ®Google Scholar
• Beaujean F., Hartmann O., Pico J., Parmentier C., Hayat M., Lemerle J., Duedari N. Incubation of autologous hone marrow graft with Asta‐Z (7557): comparative studies of hematological reconstitution after purged or non‐purged bone marrow transplantation. Pediat. Haematol. Oncol. 1987; 4: 105–115
   PubMed Web of Science ®Google Scholar
• Lopez M., Mary J. Y., Sainteny F. In vitro purging of hone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous hone marrow transplantation. Exp. Hematol. 1993; 21: 311–318
   PubMed Web of Science ®Google Scholar
• Skorski T., Kawalec M., Hoser G., Ratajczak M., Gnatowski B., Kawiak J. The kinetics of immuno‐logic and hematologic recovery in mice after lethal total body irradiation and reconstitution with syngenic bone marrow cells treated or untreated with mafosfamide (Asta Z 7654). Bone Marrow Transpl. 1988; 3: 543–551
   PubMed Web of Science ®Google Scholar
• Eckardt J. R., Roodman G. D., Boldt D. H., Clark G. M., Alvarez R., Page C., Gaskill H., LeMaistre C. F. Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMT. Bone Marrow Transpl. 1993; 11: 125–131
   PubMed Web of Science ®Google Scholar
• Preti R. A., Razis E., Ciavarella D., Fan Y., Kuhns R. E., Cook P., Wong G., Wuest D. L., Ahmed T. Clinical and laboratory comparison study of refrigerated and cryopreserved hone marrow for transplantation. Bone Marrow Transpl. 1994; 13: 253–260
   PubMed Web of Science ®Google Scholar
• Rowley S. D., Piantadosi S., Santos G. W. Correlation of hematologic recovery with CFU‐GM content of autologous hone marrow grafts treated with 4‐hydroperoxycy‐clophosphamide. Culture after cryopreservation. Bone Marrow Transpl. 1989; 4: 553–558
   PubMed Web of Science ®Google Scholar
• Pendry K., Alcorn M. J., Bumett A. K. Factors influencing haematological recovery in 53 patients with acute myeloid leukaemia in first remission after autologous hone marrow transplantation. Br. J. Haematol. 1993; 83: 45–52
   PubMed Web of Science ®Google Scholar
• Rowley S. D., Piantadosi S., Marcellus D. C., Jones R. J., Davidson N. E., Davis J. M., Kennedy J., Wiley J. M., Wingard J. R., Yeager A. M., Santos G. W. Analysis of factors predicting speed of hematologic recovery after transplantation with 4‐hydroperoxycyclophosphamide‐purged autologous hone marrow grafts. Bone Marrow Transpl. 1991; 7: 183–191
   PubMed Web of Science ®Google Scholar
• Stewart F. M., Kaiser D. L., Ishitani K. P., Pirsch G. W., Niskanen E. Progenitor cell numbers (CFU‐GM, CFU‐D, and CFU‐Mix) and hemopoietic recovery following autologous marrow transplantation. Exp. Hematol. 1989; 17: 974–980
   PubMed Web of Science ®Google Scholar
• Sheridan W. P., Morstyn G., Wolf M., Dodds A., Lusk J., Maher D., Layton J. E., Green M. D., Souza L., Fox R. M. Granulocyte colony‐stimulating factor and neutrophil recovery after high‐dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; ii: 891–895
   Google Scholar
• Gorin N. C., Coiffier B., Hayat M., Fouillard L., Kuentz M., Flesch M., Colombat P., Boivin P., Slavin S., Philip T. Recombinant human granulocyte‐macrophage colony‐stimulating factor after high‐dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non‐Hodgkin's lymphoma: a double‐blind placebo‐controlled trial. Blood 1992; 80: 1149–1157
   PubMed Web of Science ®Google Scholar
• Fay J. W., Lazarus H., Herzig R., Saez R., Stevens D. A., Collins R. H., Jr, Pineiro L. A., Cooper B. W., DiCesare J., Campion M., Felser J. M., Herzig G., Bemstein S. H. Sequential administration of recombinant human inter‐leukin‐3 and granulocyte‐macrophage colony‐stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a Phase I/II muticenter study. Blood 1994; 84: 2151–2157
   PubMed Web of Science ®Google Scholar
• Sheridan W. P., Bengley C. G., Juttner C. A., Szer J., To L. B., Mahrer D., McGrath K. M., Morstyn G., Fox R. M. Effect of peripheral‐blood progenitor cells mobilised by filgrastim (G‐CSF) on platelet recovery after high‐dose chemotherapy. Lancet 1992; i: 640–644
   Web of Science ®Google Scholar
• Bodine D. M., Seidel N. E., Zsebo K. M., Orlic D. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 1993; 82: 445–455
   PubMed Web of Science ®Google Scholar